THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. BIOCHEMICAL STUDIES.
D000469:Alkaline Phosphatase / Q000097:blood*; D000970:Antineoplastic Agents; D002066:Busulfan; D002869:Chromosome Aberrations; D003078:Colchicine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D007951:Leukemia, Myeloid; D007962:Leukocytes; D015122:Mercaptopurine; D009705:Nucleosides; D014747:Vinblastine
D000970:Antineoplastic Agents; D009705:Nucleosides; D014747:Vinblastine; D015122:Mercaptopurine; D000469:Alkaline Phosphatase; D002066:Busulfan; D003078:Colchicine
ANTINEOPLASTIC AGENTS; BLOOD ALKALINE PHOSPHATASE; BUSULFAN; CHROMOSOME ABNORMALITIES; COLCHICINE; HYDROGEN-ION CONCENTRATION; LEUKEMIA, MYELOCYTIC; LEUKOCYTES; MERCAPTOPURINE; NUCLEOSIDES; VINBLASTINE